Actrapid and Micardis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Actrapid (insulin) and Micardis (telmisartan). Common drug interactions include blood creatinine increased among females.
The phase IV clinical study analyzes what interactions people have when they take Actrapid and Micardis. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Actrapid?
Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.
What is Micardis?
Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Actrapid and Micardis together, and have interactions are studied.

What are the common drug interactions of Actrapid and Micardis, by gender? *:
female:
- Blood creatinine increased
- Hypotension (abnormally low blood pressure)
- Malaise (a feeling of general discomfort or uneasiness)
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
- General physical condition
- General physical health deterioration (weak health status)
- Dehydration (dryness resulting from the removal of water)
- Renal failure acute (rapid kidney dysfunction)
male:
n/a
What are the common drug interactions of Actrapid and Micardis, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Eating disorder
- Malaise (a feeling of general discomfort or uneasiness)
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
n/a
60+:
- Blood creatinine increased
- Hypotension (abnormally low blood pressure)
- General physical condition
- General physical health deterioration (weak health status)
- Dehydration (dryness resulting from the removal of water)
- Renal failure acute (rapid kidney dysfunction)
- Asthenia (weakness)
- Diarrhoea
- Dizziness
- Electrolyte imbalance
What are the existing conditions these people have? *
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 58.33%
- Cardiac Failure: 7 people, 58.33%
- Type 2 Diabetes: 6 people, 50.00%
- Diabetes: 3 people, 25.00%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
- Pain: 2 people, 16.67%
* Approximation only. Some reports may have incomplete information.
Do you take Actrapid and Micardis?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Actrapid and Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Actrapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Micardis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Actrapid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Micardis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on insulin and telmisartan (the active ingredients of Actrapid and Micardis, respectively), and Actrapid and Micardis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cyclobenzaprine Hydrochloride cause Agranulocytosis? - 3 seconds ago
- Could Nystatin cause Arrhythmias? - 8 seconds ago
- Could Dimenhydrinate cause Hypercalcaemia? - 10 seconds ago
- Could Zanaflex cause Anaphylaxis? - 12 seconds ago
- Could Ativan cause Pancreatitis Necrotising? - 13 seconds ago
- Could Atenolol cause Gastrointestinal Disorder? - 14 seconds ago
- Drug interactions of Escitalopram and Fungizone - 15 seconds ago
- Drug interactions of Fish Oil and Garlic Oil - 15 seconds ago
- Erection Problems and Joint Swelling - 16 seconds ago
- Drug interactions of Azithromycin and Haloperidol Lactate - 16 seconds ago